Description
In general, hematological malignancies show good response to antineoplastic agents. However, less than half of patients with hematological malignancies can be cured with chemotherapy alone. Since some antineoplastic agents show linear dose-response relationship, increasing the dose of chemotherapy may increase the antineoplastic effects, but it is precluded by the adverse effects of antineoplastic agents, so-called dose-limiting toxicities. The dose-limiting toxicity of many antineoplastic agents is myelosuppression. Therefore, hematopoietic stem cell transplantation has been investigated to allow high-dose chemotherapy over the maximum tolerated dose by supporting the hematopoietic system with the infusion of hematopoietic stem cells from a donor (allogeneic transplantation) or the patients themselves (autologous transplantation). In addition to the effect of the high-dose chemotherapy, an immunological antineoplastic effect of donor cells, so-called...
References and Further Readings
Forman SJ, Negrin RS, Antin JH, Appelbaum FR (2016) Thomas' hematopoietic cell transplantation. 5th ed, Wiley-Blackwell. ISBN: 1118416007.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this entry
Cite this entry
Kanda, Y. (2018). Hematopoietic Stem Cell Transplantation. In: Gellman, M., Turner, J. (eds) Encyclopedia of Behavioral Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6439-6_1236-2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6439-6_1236-2
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6439-6
Online ISBN: 978-1-4614-6439-6
eBook Packages: Springer Reference MedicineReference Module Medicine